Idebenone Prevents Oxidative Stress, Cell Death and Senescence of Retinal Pigment Epithelium Cells by Stabilizing BAX/Bcl-2 Ratio by Arend, Nicole et al.
E-Mail karger@karger.com
 Original Paper 
 Ophthalmologica 2015;234:73–82 
 DOI: 10.1159/000381726 
 Idebenone Prevents Oxidative Stress, Cell Death 
and Senescence of Retinal Pigment Epithelium 
Cells by Stabilizing BAX/Bcl-2 Ratio 
 Nicole Arend    Christian Wertheimer    Peter Laubichler    Armin Wolf    
Anselm Kampik    Marcus Kernt 
 Department of Ophthalmology, Ludwig Maximilian University,  Munich , Germany 
ments after treatment with H 2 O 2 . The reduction of proapop-
totic BAX and the elevation of antiapoptotic Bcl-2 under ide-
benone show that this process is rather mediated by inhibit-
ing H 2 O 2 -induced apoptosis, not necrosis.  Conclusion: In 
this study, idebenone increased survival of ARPE-19 cells and 
reduced cell death, senescence, and oxidative stress by sta-
bilizing the BAX/Bcl-2 ratio.  © 2015 S. Karger AG, Basel 
 Introduction 
 Age-related macular degeneration (AMD) is the main 
reason for severe vision loss in the elderly population 
worldwide  [1–3] . Both dry and wet forms of AMD exist. 
About 10% of AMD patients suffer from wet AMD which 
may result in rapid loss of central vision due to choroidal 
neovascularization in the central retina  [3] . The other 
90% of patients suffer from dry forms, such as geograph-
ic atrophy (GA), in which visual acuity usually decreases 
gradually  [3] . Nevertheless, due to the large number of 
patients affected, the gradual decrease in central vision is 
a major source of visual impairment in the elderly popu-
lation. GA is characterized by the atrophy of retinal pig-
ment epithelium (RPE) cells and consecutive photore-
ceptor degeneration  [3] . At present, there is no satisfac-
tory treatment for GA and dry AMD  [3] .
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 Abstract 
 Purpose: Age-related macular degeneration (AMD) is one of 
the leading causes of blindness. Degeneration of the retinal 
pigment epithelium (RPE) is pathognomonic for the disease, 
and oxidative stress plays an important role in the pathogen-
esis of this disease. This study investigates potential anti-
apoptotic and cytoprotective effects of idebenone on cul-
tured RPE cells (ARPE-19) under conditions of oxidative 
stress.  Methods: ARPE-19 cells were treated with 1–100 μ M 
idebenone. Cell viability (MTT assay), induction of intracel-
lular reactive oxygen species (ROS) and histone-associated 
DNA fragments in mono- and oligonucleosomes, expression 
of proapoptotic BAX and antiapoptotic Bcl-2 as well as se-
nescence-associated β-galactosidase (SA-β-Gal) activity 
were investigated under exposure to hydrogen peroxide 
(H 2 O 2 ).  Results: Idebenone concentrations from 1 to 20 μ M 
showed no toxic effects on ARPE-19 cells. When cells were 
treated with H 2 O 2 , pretreatment with 5, 7.5, 10, and 20 μ M 
idebenone led to a significant increase in the viability of 
ARPE-19 cells. In addition, idebenone pretreatment signifi-
cantly attenuated the induction of SA-β-Gal and intracellular 
ROS as well as the amount of histone-associated DNA frag-
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 AMD is a multifactorial disease, and the pathogenesis 
is still not completely understood. However, beside oth-
ers, increased cumulative light exposure, smoking, hemo-
dynamic abnormalities, and inflammation have been im-
plicated as risk factors  [3] . 
 There is substantial evidence that all these risk factors 
have a common denominator: abnormal increased pro-
duction of reactive oxygen species (ROS)  [4] . In this con-
text, it is of importance that RPE cells are highly suscep-
tible to oxidative stress  [5] . One reason for this is that RPE 
cells contain numerous intracellular photoreactive com-
pounds, including lipofuscin, melanin, and others, ab-
sorbing especially in the blue spectral range and thereby 
promoting the formation of oxygen radicals  [6] . In addi-
tion, numerous oxygen radical-producing enzymes as 
well as the high content of fatty acids and the high me-
tabolism rate of the RPE cells contribute to a metabolic 
imbalance and to an oxidized status  [7] . Moreover, regen-
erating all- trans -retinal from the vision circle and fatty 
acids for the metabolism of photoreceptor outer seg-
ments and the nutritional function of the RPE for the 
neuroretinal tissue result in an extremely high metabolic 
activity of RPE cells  [8] . As a result, RPE cells have to cope 
with a highly increased intracellular ROS production  [8] .
 To protect RPE cells from oxidative stress-induced cel-
lular damage, antioxidant supplementation has been pro-
posed as supporting treatment in certain forms of dry 
AMD  [9] . Nevertheless, to date, there is still no satisfac-
tory treatment for GA.
 Idebenone is a derivate of coenzyme Q10, but with a 
ten-fold higher antioxidant capacity. As a component of 
the respiratory chain it acts as a proton and electron car-
rier from complex I and II to complex III. The precise 
mechanisms of its antioxidative and cytoprotective ef-
fects are not completely understood, but a number of ex-
perimental and clinical studies demonstrated (neuro-)cy-
toprotective effects in degenerative diseases such as Fried-
reich’s ataxia  [10, 11] or Leber’s hereditary optic 
neuropathy  [12] . In addition, effects on antiapoptotic 
protein expression have been described  [13–15] .
 The present study evaluates the effect of idebenone on 
cultured human RPE cells under conditions of oxidative 
stress.
 Methods 
 Idebenone was generously provided by Santhera Pharmaceuti-
cals (Liestal, Switzerland). The compound was dissolved in di-
methyl sulfoxide (DMSO; Sigma-Aldrich, St. Louis, Mo., USA) 
and diluted with DMSO and the cell culture medium to the desired 
concentration, with a final DMSO concentration of 0.1% (v/v) for 
in vitro  studies. DMSO was added to cultures at 0.1% (v/v) as a 
solvent control.
 Ethics 
 The methods of securing human tissue were humane, included 
proper consent and approval, complied with the Declaration of 
Helsinki, and were approved by the local ethics committee.
 ARPE-19 Cell Culture 
 ARPE-19 cells, a human RPE cell line, were purchased from 
ATCC (Manassas, Va., USA) and grown in a 1: 1 mixture of Dul-
becco’s modified Eagle’s medium and Ham’s F-12 medium 
(DMEM/Ham’s F-12), supplemented with 10% FCS, 50 IU penicil-
lin/ml and 50 μg streptomycin/ml (Biochrom) at 37  °  C and 5% CO 2 
as described previously  [16] . The cell culture medium was changed 
every 48 h. 100% confluence was achieved after 72 h of growing. 
Only confluent ARPE-19 cells were used for the experiments.
 Cell Culture Treatment 
 For the tetrazolium dye-reduction assay [3-(4,5-dimethylthia-
zol-2-yl)-2,5-diphenyltetrazolium bromide (MTT)], ARPE-19 
cells were seeded in 12-well tissue culture plates upon confluence 
for 72 h and then kept in serum-free conditions (i.e. cell culture 
medium without FCS, other factors kept constant) for 24 h. After-
wards, they were exposed to various idebenone concentrations (1, 
2.5, 5, 7.5, 10, 20, 50, 75, 100, and 150 μ M ) for 48 h. To investigate 
the effects of idebenone on ARPE-19 cells regarding oxidative 
stress, we used idebenone concentrations of 5 and 10 μ M , which 
showed the strongest effects in preliminary studies. Regarding 
ROS, senescence-associated β-galactosidase (SA-β-Gal), histone-
associated DNA fragments, and BAX and Bcl-2 concentrations of 
5 and 7.5 μ M were chosen because, here, the antioxidative effect 
was most intense with a secure distance from the toxic dose. Ide-
benone has been applied as a pretreatment because as a coenzyme 
Q10 analogue it acts as an electron carrier in the respiratory chain 
 [17] . Therefore, it is able to immediately eliminate newly built rad-
icals and may be more effective than when applied afterwards. A 
previous study showed stronger effects with pre- than with post-
treatment  [18] . Also, we  [19] and others  [20–22] showed promis-
ing results with pretreatment; therefore, we chose this regimen 
again for the present study.
 Exposure to Hydrogen Peroxide 
 To test the effects of idebenone under conditions of oxidative 
stress, ARPE-19 cells were exposed to hydrogen peroxide (H 2 O 2 ). 
In preliminary studies of our laboratory, several concentrations of 
H 2 O 2 between 400 and 2,000 μ M and exposure times were tested, 
and the concentration of 750 μ M H 2 O 2 and a 2-hour treatment 
were chosen in order to produce an adequate degree of oxidative 
stress without a too strong cell injury in untreated ARPE-19 cells. 
A diagrammed presentation of this can be found in  figure 1 a. To 
investigate the effect of idebenone on H 2 O 2 -induced cellular dam-
age, cells were seeded upon confluence in 12-well plates as de-
scribed above and then exposed to the abovementioned different 
concentrations of idebenone for 48 h, but 750 μ M H 2 O 2 was added 
for the last 2 h (i.e. for 46 h idebenone only; for 2 h idebenone plus 
H 2 O 2 ). Then, the serum-free medium containing H 2 O 2 and idebe-
none was removed by carefully rinsing the cells with serum-free 
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free medium, MTT assay, quantitative detection of histone-asso-
ciated DNA fragments in mono- and dinucleosomes, and CM-
H2DCFDA staining and SA-β-Gal staining were investigated. In 
addition, RT-PCR analysis and Western blotting were performed.
 MTT Assay 
 The MTT assay was used to determine metabolic activity of 
ARPE-19 cells. The MTT assay is a well-established test for an in-
direct measurement of cell viability by determining the activity of 
the mitochondrial succinate dehydrogenase and NAD(P)H me-
tabolism. Elevated NAD(P)H as a marker of increased cellular 
metabolic activity results in an increased reduction of MTT sub-
stance. It was performed as described in the literature by Mosmann 
 [23] , with some modifications  [16, 24] . The medium was removed, 
cells were washed with PBS, and 1,000 ml/well MTT solution (1.5 
ml MTT stock, 2 mg/ml in PBS, plus 28.5 ml DMEM) was added. 
ARPE-19 cells were incubated at 37  °  C for 1 h. The formazan crys-
tals that formed were dissolved by the addition of DMSO (700 ml/
well). Absorption was measured by a scanning multiwell spectro-
photometer (Molecular Probes, Garching, Germany) at 550 nm. 
Results are expressed as the mean percentage of control extinction. 
Experiments were performed in triplicate and repeated three 
times. Untreated ARPE-19 cells of the same passage served as the 
control. Values of each sample were normalized to a ‘blank’ con-
taining DMSO only.
 Detection of SA-β-Gal Activity 
 The proportion of ARPE-19 cells positive for SA-β-Gal activity 
was determined as described by Dimri et al.  [25] . Briefly, treated 
ARPE-19 cells were washed twice with PBS and fixed with 2% 
formaldehyde and 0.2% glutaraldehyde in PBS (pH 6.0) at room 
temperature for 4 min. The cells were then washed twice with PBS 
and incubated for 8 h at 37   °   C with freshly prepared SA-β-Gal 
staining solution [1 mg/ml 5-bromo-4-chloro-3-indolyl-β- D -
galactopyranoside, 40 m M citric acid-sodium phosphate solution 
(pH 6.0), 5 m M potassium ferrocyanide, 5 m M potassium ferricya-
nide, 150 m M NaCl, and 2 m M MgCl 2 diluted in PBS] in darkness. 
Subsequently, the SA-β-Gal staining solution was removed, and 
cells were washed with PBS, examined for the development of blue 
color, and photographed at low magnification (×200) using a light 
microscope. The amount of SA-β-Gal-positive cells was counted 
in 5 high-power fields per experiment at ×200 magnification. The 
results are expressed as the mean average percentage ± SD of six 
experiments using ARPE-19 cultures from four donors.
 Detection of Intracellular ROS 
 Intracellular ROS production was detected by the method de-
scribed by Nishikawa et al.  [26] with some modifications  [27] . RPE 
cells cultured in the presence of 5 and 7.5 μ M idebenone were treat-
ed with 750 μ M H 2 O 2 as described above. Then, the cells were sup-
plemented with 5-(and-6)-chloromethyl-2 ′ ,7 ′ -di chlo ro di hydro-
fluorescein diacetate acetyl ester (CM-H2DCFDA; Molecular 
Probes, Eugene, Oreg., USA) dissolved in Krebs-Ringer bicarbon-
ate buffer (135 m M NaCl, 3.6 m M KCl, 10 m M HEPES, 5 m M 
 NaHCO 3 , 0.5 m M NaH 2 PO 4 , and 0.5 m M MgCl 2 , pH 7.4) to a final 
concentration of 10 μ M CM-H2DCFDA for 30 min and incubated 
with DMEM/F12 medium for 2 h. Subsequently, CM-H2DCFDA 
staining solution was removed, cells were washed with PBS and 
analyzed under an epifluorescence microscope (Aristoplan). The 

















































5 μM + H2O2
Idebenone
10 μM + H2O2
p = 0.05
 Fig. 1.  a Cell viability under a 2-hour treatment with different concentrations of H 2 O 2 . A clear decrease in viabil-
ity was achieved by exposure to 750 μ M H 2 O 2 .  b Treatment with H 2 O 2 led to a significant decrease in cell viabil-
ity. Pretreatment with 5 and 10 μ M idebenone significantly attenuated the decrease in viability after exposure to 
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 Detection of Histone-Associated DNA Fragments in 
Mono- and Oligonucleosomes 
 Apoptosis is characterized by membrane blebbing, condensa-
tion of cytoplasm, and activation of endogenous endonucleases. 
This leads to internucleosomal cleavage of DNA and the genera-
tion of mono- and oligonucleosomes that are tightly complexed 
with histones. To quantify apoptosis in ARPE-19 cells, detection of 
histone-associated DNA fragments in mono- and oligonu-
cleosomes was performed by ELISA. ARPE-19 cells were treated 
with idebenone (5 and 7.5 μ M ) as described above. Cells were then 
collected from culture plates and subjected to a cell death detection 
ELISA (Roche Applied Science, Indianapolis, Ind., USA) accord-
ing to the manufacturer’s recommendations  [27] . The extinction 
produced by histone-associated DNA fragments was measured 
with the ELISA reader. H 2 O 2 -treated cells produce a much higher 
extinction detected by ELISA than control cells or cells treated with 
idebenone only. But even without oxidative stress, a certain amount 
of histone-associated DNA fragments can be measured. To elimi-
nate this ‘natural’ H 2 O 2 -independent apoptosis, it is recommend-
ed by the manufacturer to examine the relative increase in histone-
associated DNA fragments caused by H 2 O 2 treatment additionally 
to idebenone or sham treatment. This increase is called ‘enrich-
ment factor’ and equals the value of extinction of H 2 O 2 -treated 
cells divided by the value of extinction of untreated cells.
 RNA Isolation and Real-Time PCR for BAX and Bcl-2 
 RNA isolation by using the guanidium thiocyanate-phenol-
chloroform extraction method and RT-PCR using the LightCycler 
System (Roche Diagnostics, Mannheim, Germany) was performed 
as described previously  [24, 28] . Quantitation of Bcl-2 and BAX 
mRNA was performed with specific primers ( table 1 ). Primers and 
probes were selected by the ProbeFinder software version 2.04. All 
primers and probes were designed to cross intron-exon boundar-
ies in order to avoid amplification of genomic DNA. All PCR prod-
ucts were sequenced to ensure product validity. To normalize for 
differences in the amount of total RNA added to each reaction, 18S 
rRNA was simultaneously processed in the same sample as an in-
ternal control. The levels of Bcl-2 and BAX mRNA were deter-
mined as the relative ratio, which was calculated by dividing the 
level of Bcl-2 or BAX mRNA by the level of the 18S rRNA house-
keeping gene in the same samples. Ratios are expressed in a deci-
mal format. All experiments were performed at least in triplicate 
and repeated three times.
 Statistical Analysis 
 Data was analyzed using SPSS 22 for Windows (SPSS Inc., Chi-
cago, Ill., USA). Quantitative results are presented as means ± stan-
dard deviations. The effect of various idebenone concentrations on 
cell viability under oxidative stress was statistically tested using the 
Mann-Whitney test for two independent samples without normal 
distribution. Statistical comparisons among the different concen-
trations of idebenone (each repeated three times and measured in 
triplicate) in testing of ROS, of histone-associated DNA fragments, 
and of expression of BAX and Bcl-2 and of SA-β-Gal were also 
performed with the Mann-Whitney test. For all statistical tests, 
p < 0.05 was considered significant.
 Results 
 Cell Viability 
 ARPE-19 cells were treated with 1, 2.5, 5, 7.5, 10, 20, 
50, 75, 100, and 150 μ M idebenone for 48 h to investigate 
potential toxic effects of this substance on the cells. Cells 
treated with concentrations between 1 and 20 μ M showed 
no difference in intracellular mitochondrial dehydroge-
nase activity, an indirect measure for cellular viability, in 
the MTT assay. An idebenone concentration of 50, 75, 
100, and 150 μ M led to a dose-dependent decrease in in-
tracellular mitochondrial dehydrogenase activity ( fig. 2 ). 
 Effect of Idebenone on H 2 O 2 -Induced Decrease in 
ARPE-19 Cell Viability 
 Results of our preliminary studies with various con-
centrations of H 2 O 2 at an exposure time of 2 h are shown 
in  figure 1 a. This time span was found to be the best in 
previous experiments with different exposure times (data 
 Table 1.  Primers used for RT-PCR





Bcl-2 19 3465 – 3483 60 58 agaggtcacgggggctaat
20 3505 – 3524 60 50 ccaggtaacaaaaccccaca
BAX 18 526 – 543 59 61 caagaccagggtggttgg
18 592 – 609 59 56 cactcccgccacaaagat































1 2.5 5 7.5 10 20 50 75 100 150
 Fig. 2. Toxicity of idebenone. Up to a concentration of 20 μ M, ide-




















   
   
   
   
   
   
   
   
   
   
   





















 Idebenone Stabilizes BAX/Bcl-2 Ratio  Ophthalmologica 2015;234:73–82 
DOI: 10.1159/000381726
77
not shown). 750 μ M appeared to be the proper concentra-
tion to gain a decrease in cell viability due to oxidative 
stress without disturbing the cell metabolism too much. 
This H 2 O 2 treatment led to a significant decrease in intra-
cellular mitochondrial dehydrogenase activity, an indi-
rect measure for cellular viability, of ARPE-19 cells in the 
MTT assay [viability of 100% in control cells vs. 67 ± 21% 
in H 2 O 2 -treated cells (p = 0.002)]. When pretreated with 
5 and 10 μ M idebenone, cells showed a viability of 81 ± 23 
and 91 ± 18%, respectively. So, pretreatment with idebe-
none led to a significantly higher viability despite the ex-
posure to H 2 O 2 (p = 0.05 for 5 μ M and p = 0.038 for 10 μ M 
idebenone;  fig. 1 b).
 Expression of SA-β-Gal 
 SA-β-Gal is a well-known marker for cell aging, estab-
lished especially in research regarding skin aging. In the 
present study, H 2 O 2 treatment led to a significant in-
crease in the expression of SA-β-Gal (p = 0.01). When 
pretreated with 5 μ M idebenone, the increase in SA-β-Gal 
expression mediated by H 2 O 2 was significantly amelio-
rated (p = 0.03;  fig. 3 ,  4 ).
 Expression of Intracellular ROS 
 There was no difference between the expression of in-
tracellular ROS in idebenone-treated and control cells. In 
contrast, H 2 O 2 -treated cells showed a significantly higher 
expression of intracellular ROS (p = 0.001). Pretreatment 
with idebenone significantly reduced the expression of 
intracellular ROS in H 2 O 2 -treated cells (p = 0.01;  fig. 4 ,  5 ).
 Detection of Histone-Associated DNA Fragments in 
Mono- and Oligosomes 
 Detection of histone-associated DNA fragments was 
performed by ELISA to investigate a possible antiapop-
totic effect of idebenone on ARPE-19 cells. The raw data 
of extinction read by ELISA are presented in  figure 6 a. To 
make the effect of H 2 O 2 and the protection by idebenone 
better visible, the data are expressed as enrichment factor 
as described above, i.e. the multiplication of apoptosis 
due to H 2 O 2 , and displayed in  figure 6 b. Here, treatment 
with 750 μ M H 2 O 2 led to a significant increase in histone-
associated DNA fragments corresponding with a signifi-
cant increase in apoptosis in control and idebenone-
treated cells (p = 0.0001). The factor by which H 2 O 2 treat-
ment elevated the expression of histone-associated DNA 
fragments compared to cells without oxidative stress was 
12.8 ± 4.1 in control cells, 10.4 ± 3.7 in cells pretreated 
with 5 μ M idebenone, and 6.9 ± 1.8 in cells pretreated with 
7.5 μ M idebenone ( fig. 6 a).  Figure 6 b shows this ‘enrich-
ment factor’ normalized to the control group (100%). 
Pretreatment with 7.5 μ M idebenone led to a significantly 
lower enrichment factor (55.9 ± 16.8%; p = 0.001) com-
pared to control cells; 5 μ M idebenone showed this by 
trend (79.2 ± 21.9%; p = 0.058), and the difference be-
tween idebenone 5 and 7.5 μ M was significant (p = 0.001). 
 mRNA Expression of BAX and Bcl-2 
 In order to confirm that the detected increase in his-
tone-associated DNA fragments is caused by apoptosis, 
not by necrosis, we quantified the mRNA expression of 
the proapoptotic protein BAX and the antiapoptotic pro-
tein Bcl-2. As both need to be in a steady balance to allow 
normal cell survival, we also calculated the BAX/Bcl-2 ra-
tio. After normalization to the control group, expression 
of BAX was 100% in control cells, 136 ± 28% in H 2 O 2 -
treated cells, 115 ± 9% in cells treated with H 2 O 2 and 5 μ M 
idebenone, and 103 ± 35% in cells treated with H 2 O 2 and 
7.5 μ M idebenone. Expression of Bcl-2 was 100% in con-
trol cells, 70 ± 20% in H 2 O 2 -treated cells, 83 ± 49% in cells 
treated with H 2 O 2 and 5 μ M idebenone, and 115 ± 57% in 
cells treated with H 2 O 2 and 7.5 μ M idebenone. Therefore, 
the BAX/Bcl-2 ratio was 100, 211 ± 86, 170 ± 83, and 112 
± 67%, respectively. So, exposure of ARPE-19 cells to 
H 2 O 2 led to a significant increase in the proapoptotic 
BAX (p = 0.037), to a significant decrease in the antiapop-
totic Bcl-2 (p = 0.034), and to a subsequent significant 
increase in the BAX/Bcl-2 ratio (p = 0.037;  fig. 7 ). Pre-
treatment with idebenone led to a dose-dependent de-
















 Fig. 3. H 2 O 2 treatment led to a significant increase in the amount 
of SA-β-Gal-positive ARPE-19 cells. Pretreatment with 5 μ M ide-
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totic Bcl-2 under oxidative stress, which resulted in a nor-
malization of the elevated BAX/Bcl-2 ratio. These results 
were clearly recognizable as shown in  figure 7 , but due to 
the relatively high standard deviation they were not sta-
tistically significant at a p level of 0.05.
 Discussion 
 To date, not all mechanisms involved in the develop-
ment and progression of AMD to retinal pigment epithe-
lial atrophy and consecutive photoreceptor degeneration 
are completely understood. Nonetheless, oxidative stress 
seems to be a central mechanism through which known 
risk factors, e.g. advanced age, smoking, or UV light, have 
an impact on retinal cell death  [4] . In addition, there 
seems to be no doubt that induction of oxidative stress 
and oxygen radicals promote cellular apoptosis. 
 Apoptosis is a cell-autonomous mechanism that is ge-
netically controlled by the dying cell, resulting in the ac-
tivation of tumor suppressor proteins  [29] and apoptosis-
initiating caspases  [30] . A number of studies found that 
apoptosis plays an important role in retinal cell death, 
both in physiological and pathological conditions, and 
particularly in AMD  [5, 31–33] . Dunaief et al.  [34] , for 
example, demonstrated in vivo the involvement of apop-
tosis in RPE cell death at the margins of GA in dry AMD 
eyes, and Hinton et al.  [31] showed an involvement of 
apoptosis in choroidal neovascularization membranes of 
patients suffering from neovascular AMD. Numerous in 
vitro investigations revealed that retinal cell apoptosis is 
mediated by oxidative stress  [5, 35, 36] . In addition, apop-















 Fig. 4. Treatment with H 2 O 2 increased the expression of intracellular ROS (upper row) and SA-β-Gal (lower row) 































p = 0.01p = 0.001
Idebenone H2O2 H2O2 +
idebenone
 Fig. 5. There was no difference in the expression of ROS between 
idebenone-treated cells and controls. H 2 O 2 treatment led to a sig-
nificant increase in fluorescence due to intracellular ROS. Pretreat-
ment with 5 μ M idebenone significantly attenuated this increase in 
ROS fluorescence. 
CM-H2DCFDA
Control Idebenone H2O2 H2O2 + idebenone
SA- -Gal
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elevated caspase levels, but also by an increase in the pro-
apoptotic protein BAX and a decrease in the antiapop-
totic protein Bcl-2  [27, 37–39] . BAX activates caspases by 
upregulating the tumor suppressor gene p53  [40, 41] , and 
Bcl-2 inhibits caspases by stabilizing the permeability of 
the mitochondrial membrane  [41] . An imbalanced rela-
tion of these proteins puts the cells in a proapoptotic state. 
Former studies showed this for several cell types  [37–39] 
and especially for retinal cells  [20, 42] .
 In this study, we were able to show that exposure of 
ARPE-19 cells to oxidative stress leads to a decrease in 
the viability of RPE cells and an increased formation of 
intracellular ROS. This decrease in viability is caused by 
RPE cell apoptosis, not necrosis, as shown by the signifi-
cantly elevated expression of histone-associated DNA 
fragments and the elevated BAX/Bcl-2 ratio. In addition, 
the strongly elevated expression of SA-β-Gal indicates 
promotion of cellular aging under H 2 O 2 . SA-β-Gal is a 
well-established marker for cellular aging, mainly known 
from dermatological studies. It represents the enzymatic 
level of cell senescence with expansion of the lysosomal 
compartment  [43] . It is only expressed by senescent, not 
presenescent cells, e.g. fibroblasts and keratinocytes  [25, 


















































































































 Fig. 6.  a Gross expression of histone-associated DNA fragments in the different treatment groups. H 2 O 2 treat-
ment significantly increased this expression.  b Elevated expression of histone-associated DNA fragments in con-
trol ARPE-19 cells due to H 2 O 2 treatment, normalized to control. Pretreatment with 5 and 7.5 μ M idebenone 
significantly attenuated apoptosis following H 2 O 2 treatment resulting in a significantly lower expression of his-
























5 μM + H2O2
Idebenone
7.5 μM + H2O2
p = 0.034
p = 0.037
 Fig. 7. mRNA expression of BAX and Bcl-2 and the BAX/Bcl-2 
ratio in control cells, H 2 O 2 -treated cells, and idebenone- plus 
H 2 O 2 -treated cells. H 2 O 2 significantly elevated the BAX/Bcl-2 ra-
tio, which indicates a disturbed balance and a shift into a proapop-
totic state. Idebenone pretreatment prior to H 2 O 2 treatment at-
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cells  [19] . So, the results of this study underline the piv-
otal role of oxidative stress in aging and apoptosis of RPE 
cells.
 While antioxidants are used to potentially prevent the 
progression of early and intermediate stages of AMD, 
still, in the majority of patients, the disease progresses 
over time and no effective treatment exists to stop apop-
totic RPE cell death in advanced nonneovascular AMD 
 [45] .
 Idebenone is a synthetic analogue of ubiquinone with 
a ten-fold higher potency. It acts as an electron carrier 
between the complexes of the respiratory chain and, 
therefore, influences the electric balance within the mito-
chondrion  [15] . Furthermore, it inhibits lipid peroxida-
tion and stabilizes the mitochondrial membrane via this 
pathway  [17, 46] . This underlines potential antiapoptotic 
as well as antioxidant effects of idebenone.
 In the present study, ARPE-19 cells pretreated with 
idebenone showed significantly less formation of intra-
cellular ROS after exposure to H 2 O 2 . This indicates the 
potential of idebenone to ameliorate the cytotoxic effects 
of oxidative stress on RPE cells as a potential approach to 
prevent progression of dry AMD. In addition, cells pre-
treated with idebenone showed significantly better viabil-
ity under oxidative stress. 
 An important finding of our study is that idebenone 
inhibited an increase in SA-β-Gal in RPE cells under the 
conditions of oxidative stress. As mentioned above, the 
SA-β-Gal enzyme is strongly correlated with ageing pro-
cesses. This may indicate an antiaging effect of ideben-
one.
 Previous studies demonstrated antiapoptotic effects of 
idebenone on several cell types  [19, 47–49] . To date, the 
use of idebenone and research regarding idebenone are 
focused on its protective effects on neuronal cells and tis-
sues. The first studies evaluated effects on the murine 
brain under hypoxia  [50] ; later on, it became a clinical 
treatment for patients with Friedreich’s ataxia  [10] and 
Leber’s hereditary optic neuropathy  [12] . Our recently 
published study showed its antiapoptotic, antioxidative, 
and antiaging effects on primary optic nerve head astro-
cytes in terms of glaucoma treatment  [19] . Rather few 
studies evaluated other tissues, such as kidney, and also 
showed promising antioxidative effects  [51] . AMD is an 
important oxidative stress-related eye disease whose 
treatment options are still not exhausted  [3] . The epithe-
lial tissue of the retina plays an important role in the 
pathogenesis of this disease  [3] . Therefore, one aim of our 
study was to evaluate the effects of idebenone on RPE cell 
apoptosis after exposure to oxidative stress. H 2 O 2 treat-
ment led to a significant increase in apoptosis, which 
could be demonstrated in terms of significantly more his-
tone-associated DNA fragments and an elevated BAX/
Bcl-2 ratio due to an increase in the proapoptotic BAX 
and a decrease in the antiapoptotic Bcl-2. Idebenone sig-
nificantly reduced histone-associated DNA fragments in 
a dose-dependent manner and led to a normalization of 
the BAX/Bcl-2 ratio. These findings indicate a protective 
impact of idebenone on RPE cell apoptosis after exposure 
to oxidative stress. Thus, the present study contributes to 
the evaluation of idebenone as a protective agent in non-
neuronal tissue.
 We are aware that we did not provide confirming data 
from an animal model. However, many in vivo studies 
showed much potential of idebenone against oxidative 
stress in the eye  [12, 52, 53] and other organs  [13, 21, 54] . 
Antioxidants already are a major pillar of AMD therapy, 
but they are still not fully satisfactory. Therefore, ideben-
one as an agent which can prevent optic nerve head astro-
cytes and retinal ganglion cells from apoptosis and which 
can successfully treat Leber’s hereditary optic neuropathy 
is worth to be further investigated regarding AMD ther-
apy. The present study makes a small contribution to this 
objective.
 Conclusion 
 Our experiments show substantial cytoprotective ef-
fects of idebenone mediated by inhibition of oxidative 
stress and protection of RPE cells from cellular aging pro-
cesses. This leads to a significant inhibition of oxidative 
stress-related apoptosis of RPE cells. Therefore, our in vi-
tro results imply that idebenone may have the required 
properties of a potential future therapeutic agent of AMD 
in vivo.
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